Redx Pharma (REDX) RNS Announcements

Add to Alert list
Date Time Source Announcement
09 Mar 2023 11:15 AM
RNS
Form 8 (OPD) - Redx Pharma Plc
08 Mar 2023 09:05 AM
RNS
Second Price Monitoring Extn
08 Mar 2023 09:00 AM
RNS
Price Monitoring Extension
08 Mar 2023 07:00 AM
RNS
RXC004 Topline Data From a Phase 2 Module
01 Mar 2023 07:00 AM
RNS
Redx to Present at Cowen Health Care Conference
23 Feb 2023 07:15 AM
RNS
Recommended Business Combination
15 Feb 2023 04:38 PM
RNS
Notice of AGM
09 Feb 2023 07:00 AM
RNS
Progress Update on RXC007 Clinical Programme
23 Jan 2023 07:00 AM
RNS
Redx to Present at Wnt & ß-Catenin Pathway Summit
21 Dec 2022 07:00 AM
RNS
New Grant of Options
20 Dec 2022 07:00 AM
RNS
Final Results for the Year Ended 30 September 2022
16 Dec 2022 07:00 AM
RNS
Clinical Trial Agreement with MSD
13 Dec 2022 07:00 AM
RNS
Notice of Preliminary Results
17 Nov 2022 07:00 AM
RNS
Redx to Present Poster at IBD Nordic Conference
10 Nov 2022 02:00 PM
RNS
RXC004 Phase 2 Combination Arms to Open Enrolment
10 Nov 2022 07:00 AM
RNS
Redx to Present at Jefferies London
07 Nov 2022 07:00 AM
RNS
Redx Presenting at AFDD meeting
03 Nov 2022 07:00 AM
RNS
Redx to Present RXC004 Phase 1 Combination Data
27 Oct 2022 07:00 AM
RNS
Redx to Present Poster at ASN Kidney Week
11 Oct 2022 07:00 AM
RNS
First Patient Dosed in Phase 2a Trial for RXC007
03 Oct 2022 07:00 AM
RNS
Redx Presents RXC007 Preclinical and Phase 1 Data
29 Sep 2022 07:41 AM
RNS
Redx to Present Poster on RXC007 at ICLAF
06 Sep 2022 07:00 AM
RNS
TR-1: Notification of major holdings
31 Aug 2022 07:00 AM
RNS
Redx to Present at the ERS International Congress
05 Aug 2022 11:52 AM
RNS
Completion of Placing and Director/PDMR Dealings
03 Aug 2022 01:43 PM
RNS
Proposed Secondary Placing of Shares via ABB
26 Jul 2022 01:47 PM
RNS
Exercise of Options, PDMR Dealing and TVR
11 Jul 2022 07:00 AM
RNS
Redx to Present at Virtual Investor Forum
27 Jun 2022 07:00 AM
RNS
Encouraging Data on Porcupine and ROCK Inhibitors
23 Jun 2022 07:00 AM
RNS
Interim Results for the Six Months Ended 31 March
20 Jun 2022 07:00 AM
RNS
Redx to Present at the ECM Congress
16 Jun 2022 07:00 AM
RNS
Notice of Interim Results
15 Jun 2022 07:00 AM
RNS
Pan-RAF Inhibitor to Enter Clinical Development
09 Jun 2022 04:34 PM
RNS
TR-1: Notification of major holdings
08 Jun 2022 01:28 PM
RNS
TR-1: Notification of major holdings
07 Jun 2022 08:11 AM
RNS
Admission of Placing Shares
06 Jun 2022 11:56 AM
RNS
Results of General Meeting
30 May 2022 07:00 AM
RNS
Redx Presents Poster on RXC004 at ASCO
25 May 2022 07:00 AM
RNS
Redx to Present at Jefferies Healthcare Conference
20 May 2022 07:00 AM
RNS
New Grant of Options
19 May 2022 02:34 PM
RNS
New Grant of Options
19 May 2022 12:14 PM
RNS
Result of Accelerated Bookbuild
18 May 2022 06:28 PM
RNS
Launch of Placing via Accelerated Bookbuild
27 Apr 2022 03:00 PM
RNS
Redx to Present at ASCO
08 Apr 2022 06:00 PM
RNS
Redx Presents Encouraging RXC004 Preclinical Data
05 Apr 2022 07:00 AM
RNS
Collaboration with the Garvan Institute
30 Mar 2022 07:00 AM
RNS
Nomination of Clinical Development Candidate
24 Mar 2022 07:00 AM
RNS
Redx to Present at the AACR Annual Meeting
10 Mar 2022 07:00 AM
RNS
Redx Presents Encouraging Phase 1 Data for RXC007
09 Mar 2022 07:00 AM
RNS
Board Committee Changes
UK 100

Latest directors dealings